Evidence map›Paper›PMID 22910436›Full record

ArticlePLoS pathogens2012

Activation and proteolytic activity of the Treponema pallidum metalloprotease, pallilysin.

Simon Houston, Rebecca Hof, Lisa Honeyman, Julia Hassler, Caroline E Cameron

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 46 citations in OpenAlex.

  1. Frontiers in immunology · 2026
    Review
  2. Frontiers in immunology · 2026
    Article
  3. Participants inFrontiers in immunology · 2025
    Review
  4. In-Depth Proteome Coverage of In Vitro-CulturedJournal of proteome research · 2024
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Leptolysin, aFrontiers in cellular and infection microbiology · 2022
    Article
  10. Article
  11. Article
  12. Frontiers in cellular and infection microbiology · 2018
    Article
  13. Syphilis.Nature reviews. Disease primers · 2017
    Review
  14. Article
  15. Article
  16. PathogenicFrontiers in microbiology · 2017
    Article
  17. Vaccine development for syphilis.Expert review of vaccines · 2017
    Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Simon HoustonDepartment of Biochemistry and Microbiology, University of Victoria, Victoria, British Columbia, Canada.
Rebecca Hof
Lisa Honeyman
Julia Hassler
Caroline E Cameron
University of Victoria · CA

Funding

Extracellular Matrix Adhesins of Treponema pallidumR01AI051334 · NIAID · UNIVERSITY OF WASHINGTON · PI CAMERON, CAROLINE E · 2002 to 2017
$3.4M
Extracellular Matrix Adhesins of Treponema pallidumR37AI051334 · NIAID · UNIVERSITY OF VICTORIA · PI CAROLINE E CAMERON · 2019 to 2026
$2.3M
NIAID NIH HHS AI-051334NIAID NIH HHS R01 AI051334NIAID NIH HHS R37 AI051334
6 · The paper itself

Abstract

Treponema pallidum is a highly invasive pathogen that undergoes rapid dissemination to establish widespread infection. Previous investigations identified the T. pallidum adhesin, pallilysin, as an HEXXH-containing metalloprotease that undergoes autocatalytic cleavage and degrades laminin and fibrinogen. In the current study we characterized pallilysin's active site, activation requirements, cellular location, and fibrin clot degradation capacity through both in vitro assays and heterologous treponemal expression and degradation studies. Site-directed mutagenesis showed the pallilysin HEXXH motif comprises at least part of the active site, as introduction of three independent mutations (AEXXH [H¹⁹⁸A], HAXXH [E¹⁹⁹A], and HEXXA [H²⁰²A]) abolished pallilysin-mediated fibrinogenolysis but did not adversely affect host component binding. Attainment of full pallilysin proteolytic activity was dependent upon autocatalytic cleavage of an N-terminal pro-domain, a process which could not occur in the HEXXH mutants. Pallilysin was shown to possess a thrombin cleavage site within its N-terminal pro-domain, and in vitro studies confirmed cleavage of pallilysin with thrombin generates a truncated pallilysin fragment that has enhanced proteolytic activity, suggesting pallilysin can also exploit the host coagulation process to facilitate protease activation. Opsonophagocytosis assays performed with viable T. pallidum demonstrated pallilysin is a target of opsonic antibodies, consistent with a host component-interacting, surface-exposed cellular location. Wild-type pallilysin, but not the HEXXA mutant, degraded fibrin clots, and similarly heterologous expression of pallilysin in the non-invasive spirochete Treponema phagedenis facilitated fibrin clot degradation. Collectively these results identify pallilysin as a surface-exposed metalloprotease within T. pallidum that possesses an HEXXH active site motif and requires autocatalytic or host-mediated cleavage of a pro-domain to attain full host component-directed proteolytic activity. Furthermore, our finding that expression of pallilysin confers upon T. phagedenis the capacity to degrade fibrin clots suggests this capability may contribute to the dissemination potential of T. pallidum.

Indexed as

Adhesins, BacterialAmino Acid MotifsAnimalsCatalytic DomainEnzyme ActivationFibrinFibrinogenLamininMetalloproteasesPhagocytosisRabbitsThrombinTreponema pallidumZincAdhesins, Bacterialadhesin, Treponema pallidumFibrinFibrinogenLamininMetalloproteasesThrombinZinc

Identifiers

PMID22910436
PMCPMC3406077
OpenAlexW2015455006

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.